The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said today at a Senate Health, Education, Labor and Pensions Committee hearing. "This has to be an evidence-based approach — getting the medical therapeutics, vaccines, remdesivir, whichever it happens to be, to the people in need," Hahn said. 

The committee posed questions around reopening, testing and vaccines. Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci, M.D., said that communities that disregard "the checkpoints that we put in our guidelines about when it is safe to proceed in pulling back on mitigation" may "trigger an outbreak that you may not be able to control." Nursing home and long-term care facility testing and data reporting also were discussed.

Related News Articles

Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Headline
The National Institutes of Health Oct. 10 released results of a study that found that infection from COVID-19 in the first wave of the pandemic appeared to…